Avantor, Inc. Restructuring Charges
Avantor, Inc. (AVTR) reported Restructuring Charges of $29.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-02-11
- Avantor, Inc. restructuring charges for the quarter ending 2025-12-31 was $1.80M, a 260.00% increase year-over-year.
- Avantor, Inc. restructuring charges for the quarter ending 2025-09-30 was $2.20M, a 95.55% decline year-over-year.
- Avantor, Inc. restructuring charges for the quarter ending 2024-12-31 was $500.00K, a 94.12% decline year-over-year.
- Avantor, Inc. restructuring charges for the quarter ending 2024-09-30 was $49.40M, a 709.84% increase year-over-year.
- Avantor, Inc. restructuring charges for fiscal 2025 was $29.80M, a 64.01% decline from fiscal 2024.
- Avantor, Inc. restructuring charges for fiscal 2024 was $82.80M, a 212.45% increase from fiscal 2023.
- Avantor, Inc. restructuring charges for fiscal 2023 was $26.50M, a 657.14% increase from fiscal 2022.
- Avantor, Inc. restructuring charges for fiscal 2022 was $3.50M, a 33.96% decline from fiscal 2021.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $4.00M derived: sum of 2 quarters · filed 2026-02-11 | $29.80M 10-K · filed 2026-02-11 | |
| 2025-09-30 | $2.20M 10-Q · filed 2025-10-29 | $28.00M 10-Q · filed 2025-10-29 | ||
| 2024-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $49.90M derived: sum of 2 quarters · filed 2026-02-11 | $82.80M 10-K · filed 2026-02-11 | |
| 2024-09-30 | $49.40M 10-Q · filed 2025-10-29 | $82.30M 10-Q · filed 2025-10-29 | ||
| 2023-12-31 | $8.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $14.60M derived: sum of 2 quarters · filed 2026-02-11 | $21.80M derived: sum of 3 quarters · filed 2026-02-11 | $26.50M 10-K · filed 2026-02-11 |
| 2023-09-30 | $6.10M 10-Q · filed 2024-10-25 | $13.30M derived: sum of 2 quarters · filed 2024-10-25 | $18.00M 10-Q · filed 2024-10-25 | $17.80M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-06-30 | $7.20M 10-Q · filed 2023-07-28 | $11.90M 10-Q · filed 2023-07-28 | $11.70M derived: sum of 3 quarters · filed 2025-02-07 | $13.00M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-03-31 | $4.70M 10-Q · filed 2023-04-28 | $4.50M derived: sum of 2 quarters · filed 2025-02-07 | $5.80M derived: sum of 3 quarters · filed 2025-02-07 | $6.30M derived: sum of 4 quarters · filed 2025-02-07 |
| 2022-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $1.10M derived: sum of 2 quarters · filed 2025-02-07 | $1.60M derived: sum of 3 quarters · filed 2025-02-07 | $3.50M 10-K · filed 2025-02-07 |
| 2022-09-30 | $1.30M 10-Q · filed 2023-10-27 | $1.80M derived: sum of 2 quarters · filed 2023-10-27 | $3.70M 10-Q · filed 2023-10-27 | $6.80M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $500.00K 10-Q · filed 2023-07-28 | $2.40M 10-Q · filed 2023-07-28 | $5.50M derived: sum of 3 quarters · filed 2024-02-14 | $5.90M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $1.90M 10-Q · filed 2023-04-28 | $5.00M derived: sum of 2 quarters · filed 2024-02-14 | $5.40M derived: sum of 3 quarters · filed 2024-02-14 | $5.60M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $3.50M derived: sum of 2 quarters · filed 2024-02-14 | $3.70M derived: sum of 3 quarters · filed 2024-02-14 | $5.30M 10-K · filed 2024-02-14 |
| 2021-09-30 | $400.00K 10-Q · filed 2022-10-28 | $600.00K derived: sum of 2 quarters · filed 2022-10-28 | $2.20M 10-Q · filed 2022-10-28 | $7.30M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $200.00K 10-Q · filed 2022-07-29 | $1.80M 10-Q · filed 2022-07-29 | $6.90M derived: sum of 3 quarters · filed 2023-02-14 | $9.20M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $1.60M 10-Q · filed 2022-04-29 | $6.70M derived: sum of 2 quarters · filed 2023-02-14 | $9.00M derived: sum of 3 quarters · filed 2023-02-14 | $12.20M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $5.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $7.40M derived: sum of 2 quarters · filed 2023-02-14 | $10.60M derived: sum of 3 quarters · filed 2023-02-14 | $11.80M 10-K · filed 2023-02-14 |
| 2020-09-30 | $2.30M 10-Q · filed 2021-10-29 | $5.50M derived: sum of 2 quarters · filed 2021-10-29 | $6.70M 10-Q · filed 2021-10-29 | $11.20M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $3.20M 10-Q · filed 2021-07-30 | $4.40M 10-Q · filed 2021-07-30 | $8.90M derived: sum of 3 quarters · filed 2022-02-11 | $22.30M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $1.20M 10-Q · filed 2021-04-28 | $5.70M derived: sum of 2 quarters · filed 2022-02-11 | $19.10M derived: sum of 3 quarters · filed 2022-02-11 | $20.00M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $17.90M derived: sum of 2 quarters · filed 2022-02-11 | $18.80M derived: sum of 3 quarters · filed 2022-02-11 | $24.30M 10-K · filed 2022-02-11 |
| 2019-09-30 | $13.40M 10-Q · filed 2020-10-27 | $14.30M derived: sum of 2 quarters · filed 2020-10-27 | $19.80M 10-Q · filed 2020-10-27 | $43.90M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $900.00K 10-Q · filed 2020-07-29 | $6.40M 10-Q · filed 2020-07-29 | $30.50M derived: sum of 3 quarters · filed 2021-02-16 | $47.20M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $5.50M 10-Q · filed 2020-04-29 | $29.60M derived: sum of 2 quarters · filed 2021-02-16 | $46.30M derived: sum of 3 quarters · filed 2021-02-16 | $79.20M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $24.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $40.80M derived: sum of 2 quarters · filed 2021-02-16 | $73.70M derived: sum of 3 quarters · filed 2021-02-16 | $81.20M 10-K · filed 2021-02-16 |
| 2018-09-30 | $16.70M 10-Q · filed 2019-11-05 | $49.60M derived: sum of 2 quarters · filed 2019-11-05 | $57.10M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $32.90M 10-Q · filed 2019-08-06 | $40.40M 10-Q · filed 2019-08-06 | ||
| 2017-12-31 | $29.60M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |